Literature DB >> 8370079

Suppression of local and systemic GVHR by supernatants from human choriocarcinoma cell lines.

L Krishnan1, R Kinsky, G Chaouat, G P Talwar, R Raghupathy.   

Abstract

Graft versus host reaction (GVHR) and host versus graft reactivity during pregnancy share at least some cellular pathways. Immunosuppression mediated by placental suppressor factors may actively contribute to the survival of the conceptus in the immunocompetent mother. We have previously reported that supernatants from human choriocarcinoma cell lines inhibit mitogen-activated and antigen-activated proliferation of lymphoid cells. From this perspective, we investigated the capacity of supernatants from human choriocarcinoma cell lines (HCS) to suppress in vivo graft versus host reactions in mice. HCS was tested for its ability to block both local as well as systemic GVHR induced by the injection of parental cells into F1 mice. HCS mediates profound suppression of acute and chronic GVHR. These results confirm that human choriocarcinoma cell lines secrete a potent immunosuppressive factor(s) which can efficiently modulate immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370079     DOI: 10.1006/cimm.1993.1205

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  A corpus luteum is not a prerequisite for the expression of progesterone induced blocking factor by T-lymphocytes a week after implantation.

Authors:  J H Check; J Szekeres-Bartho; P Nazari; Y Katz; M L Check
Journal:  J Assist Reprod Genet       Date:  2001-11       Impact factor: 3.412

2.  Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells.

Authors:  N Kvirkvelia; I Vojnovic; T D Warner; V Athie-Morales; P Free; N Rayment; B M Chain; T W Rademacher; T Lund; I M Roitt; P J Delves
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.